Prescription drug · ANDA
Flunisolide NDC 50742-317
Flunisolide .25 mg/mL · Solution · Nasal · Ingenus Pharmaceuticals, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50742-317-25 | 5074203172550742031725 | 1 BOTTLE, PUMP in 1 CARTON (50742-317-25) / 25 mL in 1 BOTTLE, PUMPMarketed from Jun 23, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Flunisolide
- Generic name (nonproprietary)
- flunisolide
- Active ingredients
- Flunisolide — .25 mg/mL
- Dosage form
- Solution
- Route
- Nasal
- Labeler
- Ingenus Pharmaceuticals, LLCNDC labeler code 50742
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207802
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 50742-317_139fb92c-bb10-4ee9-8572-679ac540aa27SPL ID 139fb92c-bb10-4ee9-8572-679ac540aa27SPL set ID f39cae46-c68f-47ef-82f3-4fd3dd46c74cRxCUI 1797863UNII QK4DYS664X
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Nasal products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450742031725followed by a unit qualifier and the quantityPackage 50742-0317-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Flunisolide nasal solution is indicated for the treatment of the nasal symptoms of seasonal or perennial rhinitis. Flunisolide nasal solution should not be used in the presence of untreated localized infection involving nasal mucosa.
Excerpt only. Read the full label for complete information.
About NDC 50742-317
- What is NDC 50742-317?
- 50742-317 is the product NDC for Flunisolide, Flunisolide .25 mg/mL solution, listed with the FDA by Ingenus Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Flunisolide.
- What is the active ingredient?
- Flunisolide.
- Who is the labeler?
- Ingenus Pharmaceuticals, LLC, NDC labeler code 50742. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Flunisolide?
- 2 other product NDCs are listed under this name. See all Flunisolide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Flunisolide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Flunisolide | Flunisolide .25 mg/mL | SolutionNasal | Oceanside Pharmaceuticals | 68682-344 | 68682-0344-25 |
| Flunisolide | Flunisolide .25 mg/mL | SolutionNasal | Bausch & Lomb Incorporated | 24208-344 | 24208-0344-25 |